Felicia F. Norwood - 01 Mar 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President,Gov Health Ben
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2024
Net transactions value: -$2,446,637
Form type: 4
Filing time: 05 Mar 2024, 16:25:50 UTC
Previous filing: 19 Sep 2023
Next filing: 19 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$2,446,637	-4,902	-15%	$499.11	28,541	01 Mar 2024	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,405	+8.4%	$0.000000	30,946	01 Mar 2024	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9,152	+30%	$0.000000	40,098	01 Mar 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+9,280		$0.000000	9,280	01 Mar 2024	Common Stock	9,280	$499.11	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
F3	Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4	The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.